Clinical Challenges: How Early Can We Spot Alzheimer’s?
Alzheimer's disease clinical trials are moving toward earlier and earlier intervention, based on the assumption that this may prevent…
Browsing Tag
amyloid beta
Amydis Receives NIH Grant Award to Develop a Novel Tau Retinal Tracer for…
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in…
A Drug to Treat Alzheimer’s Was Approved. Now What?
Now that the FDA has approved Biogen's aducanumab (Aduhelm), the controversial new drug for…
Will Insurers Pay for New Alzheimer’s Drug?
Biogen's Alzheimer's drug aducanumab (Aduhelm) may have been cleared by the FDA, but its uptake…
Controversial Alzheimer’s Drug Wins FDA Approval
The controversial Alzheimer's treatment aducanumab (Aduhelm) won FDA approval Monday using the…